These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35418024)

  • 21. Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.
    Shimada YJ; Passeri JJ; Baggish AL; O'Callaghan C; Lowry PA; Yannekis G; Abbara S; Ghoshhajra BB; Rothman RD; Ho CY; Januzzi JL; Seidman CE; Fifer MA
    JACC Heart Fail; 2013 Dec; 1(6):480-7. PubMed ID: 24621999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mid-ventricular hypertrophic obstructive cardiomyopathy presenting with acute myocardial infarction.
    Sato Y; Matsumoto N; Matsuo S; Yoda S; Kunimoto S; Saito S
    Tex Heart Inst J; 2007; 34(4):475-8. PubMed ID: 18172535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial size and left ventricular hypertrophy correlate with myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Prinz C; Hering D; Bitter T; Horstkotte D; Faber L
    Acta Cardiol; 2011 Apr; 66(2):153-7. PubMed ID: 21591572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical correction of hypertrophic obstructive cardiomyopathy in a patient with severe hypertrophy and septal myocardial fibrosis.
    Borisov KV
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):769-71. PubMed ID: 22761117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
    Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
    J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.
    Ferrazzi P; Spirito P; Iacovoni A; Calabrese A; Migliorati K; Simon C; Pentiricci S; Poggio D; Grillo M; Amigoni P; Iascone M; Mortara A; Maron BJ; Senni M; Bruzzi P
    J Am Coll Cardiol; 2015 Oct; 66(15):1687-96. PubMed ID: 26449139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
    Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
    J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE PLACE OF CARDIAC COMPUTED TOMOGRAPHY IN PREOPERATIVE PLANNING OF EXTENDED SEPTAL MYECTOMY IN PATIENTS WITH OBSTRUCTIVE FORM OF HYPERTROPHIC CARDIOMYOMATHY.
    Tregubova MO; Rudenko KB; Lazoryshynets VV; Fedkiv SV; Trembovetskaya OM; Danchenko PA; Vitkovsky YI; Ishchenko MS; Gavrylyshyn AY; Parfentyeva VV; Stukov YY
    Probl Radiac Med Radiobiol; 2020 Dec; 25():592-606. PubMed ID: 33361864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic cardiomyopathy with dynamic obstruction and high left ventricular outflow gradients associated with paradoxical apical ballooning.
    Sherrid MV; Riedy K; Rosenzweig B; Ahluwalia M; Arabadjian M; Saric M; Balaram S; Swistel DG; Reynolds HR; Kim B
    Echocardiography; 2019 Jan; 36(1):47-60. PubMed ID: 30548699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
    Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence of left ventricular outflow tract obstruction after left anterior descending coronary artery revascularization in a patient with hypertrophic obstructive cardiomyopathy.
    Jaoudé SJ; Achouh PE; Ashoush RA; Jebara VA
    Ann Thorac Surg; 2002 Feb; 73(2):649-50. PubMed ID: 11848096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy.
    Xiao Y; Sun Y; Tian T; Wang TJ; Zhao RX; Zhang Y; Wang LP; Liu YX; Lu CX; Zhou XL; Yang WX
    Am J Med Sci; 2021 Sep; 362(3):260-267. PubMed ID: 34266644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular late potentials and myocardial fibrosis in hypertrophic cardiomyopathy.
    Matsuki A; Kawasaki T; Kawamata H; Sakai C; Harimoto K; Kamitani T; Yamano M; Matoba S
    J Electrocardiol; 2020; 58():87-91. PubMed ID: 31790854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: The Utility of Myocardial Strain Based on Cardiac MR Tissue Tracking.
    She JQ; Guo JJ; Yu YF; Zhao SH; Chen YY; Ge MY; Zeng MS; Jin H
    J Magn Reson Imaging; 2021 Jan; 53(1):51-60. PubMed ID: 32798304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.
    Almaas VM; Haugaa KH; Strøm EH; Scott H; Smith HJ; Dahl CP; Geiran OR; Endresen K; Aakhus S; Amlie JP; Edvardsen T
    Heart; 2014 Apr; 100(8):631-8. PubMed ID: 24368281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
    J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitral valve replacement and septal myectomy for hypertrophic obstructive cardiomyopathy.
    Furukawa K; Hayase T; Yano M
    Gen Thorac Cardiovasc Surg; 2014 Mar; 62(3):181-3. PubMed ID: 23546770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.